QUOTE AND NEWS
Marketwire  Dec 19  Comment 
HOUSTON, TX -- (Marketwire) -- 12/19/11 -- Power3 Medical Products, Inc. (OTCBB: PWRM), a biotechnology company, announced today the assembly of the foundational elements of its initiative to enter the adult stem cell arena, including: 1. A body of
Penny Stock DD  Dec 28  Comment 
Power3 Medical Products, Inc. (OTC:PWRM) last surged by 3.75 percent to $0.0249 as on December 27th, 2010. Its total traded volume stood at 1.24 million shares as compared to the average volume of 2.38 million shares per day. The company’s...
Marketwire  Dec 23  Comment 
HOUSTON, TX -- (Marketwire) -- 12/23/10 -- Power3 Medical Products, Inc. (OTCBB: PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, today announced
Penny Stock DD  Dec 8  Comment 
Power3 Medical Products, Inc. (PWRM.OB) is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of...
Marketwire  Sep 10  Comment 
HOUSTON, TX -- (Marketwire) -- 09/10/10 -- Power3 Medical Products, Inc. (OTCBB: PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced today
Marketwire  Sep 8  Comment 
HOUSTON, TX -- (Marketwire) -- 09/08/10 -- Power3 Medical Products, Inc. (OTCBB: PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced today
Globe Newswire  May 27  Comment 
CALGARY, Alberta, May 27, 2010 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Power3 Medical Products, Inc. (OTCBB:PWRM). Skymark Research is currently
Globe Newswire  Feb 3  Comment 
HOUSTON, Feb. 3, 2010 (GLOBE NEWSWIRE) -- Power3 Medical Products, Inc. (OTCBB:PWRM) announced that 4 abstracts covering results from clinical validation trials of the NuroPro® AD test for Alzheimer's disease were submitted to the 2010 annual
Globe Newswire  Feb 2  Comment 
DALLAS, Feb. 2, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotechnology company Power 3 Medical Products Inc. (OTCBB:PWRM). The report includes financial, comparative and investment analyses, and industry
Globe Newswire  Jan 20  Comment 
HOUSTON, Jan. 20, 2010 (GLOBE NEWSWIRE) -- Power3 Medical Products, Inc. (OTCBB:PWRM) is pleased to announce that the company will be a sponsor and have an exhibit booth at the 4th Annual Conference of the Alzheimer's Drug Discovery Foundation on





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki